1-4 of 4
Hanh Nguyen
Close
Sort by
Journal Articles

Generation of Potent Tumor-Specific CTLs from High-Dose IL-2 Activated naïve CD8 T Cells with Overcoming the Tumor-Derived Immune Suppression

Hong-Hanh Nguyen, Dong-hwan Kim, Hyun-Ju Lee, Sung-Hoon Jung, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD, Deok-Hwan Yang, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4973.
https://doi.org/10.1182/blood.V124.21.4973.4973
Published: 2014
Journal Articles

Ras-Pathway Inhibition With Targeted Therapies Abrogates Self-Renewal In Acute Myelogenous Leukemia

Rebecca S. LaRue, PhD, Hanh Nguyen, Karen Sachs, Nurul Azyan Mohd Hassan, Ernesto Diaz-Flores, PhD, Susan K. Rathe, Aaron G. Sarver, Ph.D., Sean C. Bendall, Ngoc A. Ha, Miechaleen D. Diers, B.S., Garry P. Nolan, PhD, Kevin Shannon, MD, Zohar Sachs, MD, PhD, David A. Largaespada, PhD
Journal: Blood
Blood (2013) 122 (21): 819.
https://doi.org/10.1182/blood.V122.21.819.819
Published: 2013
Journal Articles

Activated NRAS Mediates Self-Renewal Capacity in AML by Facilitating the Mll/AF9 -Specified Gene Expression Signature

Zohar Sachs, MD, PhD, Hanh Nguyen, Nurul Azyan Mohd Hassan, Susan K Rathe, Karen Sachs, Ph. D., Ernesto Diaz-Flores, PhD, Sean C Bendall, PhD, Miechaleen D Diers, Garry P. Nolan, Ph. D., Kevin M. Shannon, MD, David A. Largaespada, PhD
Journal: Blood
Blood (2012) 120 (21): 5116.
https://doi.org/10.1182/blood.V120.21.5116.5116
Published: 2012
Journal Articles

XmAb®5592 Fc-Engineered Humanized Anti-HM1.24 Monoclonal Antibody Has Potent in Vitro and In Vivo Efficacy against Multiple Myeloma.

Yu-Tzu Tai, Ph.D., Umesh Muchhal, Ph.D., Xian-Feng Li, MS, Sabikun Nahar, B.S., Weihua Song, MD, Holly Horton, Ph.D, Hanh Nguyen, Sher Karki, John Desjarlais, Nikhil C. Munshi, MD, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 609.
https://doi.org/10.1182/blood.V114.22.609.609
Published: 2009